Literature DB >> 20385860

Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.

Eveline Snelders1, Anna Karawajczyk, Gijs Schaftenaar, Paul E Verweij, Willem J G Melchers.   

Abstract

Molecular studies have shown that the majority of azole resistance in Aspergillus fumigatus is associated with amino acid substitutions in the cyp51A gene. To obtain insight into azole resistance mutations, the cyp51A gene of 130 resistant and 76 susceptible A. fumigatus isolates was sequenced. Out of 130 azole-resistant isolates, 105 contained a tandem repeat of 34 bp in the promoter region and a leucine-to-histidine substitution in codon 98 (designated TR/L98H). Additionally, in 12 of these TR/L98H resistant isolates, the mutations S297T and F495I were found, and in 1 isolate, the mutation F495I was found. In eight azole-resistant isolates, known azole resistance mutations were detected in codon G54, G138, or M220. In three azole-susceptible isolates, the mutation E130D, L252L, or S400I was found and in 13 azole-susceptible isolates but also in 1 azole-resistant isolate, the mutations F46Y, G98G, M172V, N248T, D255E, L358L, E427K, and C454C were found. All of the nonsynonymous mutations, apart from the mutations in codons G54, G138, and M220 and L98H, were located at the periphery of the protein, as determined by a structural model of the A. fumigatus Cyp51A protein, and were predicted neither to interact with azole compounds nor to affect structural integrity. Therefore, this wide diversity of mutations in the cyp51A gene in azole-susceptible A. fumigatus isolates is not correlated with azole resistance. Based on the Cyp51A protein homology model, the potential correlation of a mutation to azole resistance can be predicted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385860      PMCID: PMC2876375          DOI: 10.1128/AAC.01599-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives.

Authors:  D F Lewis; A Wiseman; M H Tarbit
Journal:  J Enzyme Inhib       Date:  1999

Review 2.  The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus.

Authors:  M E da Silva Ferreira; A L Colombo; I Paulsen; Q Ren; J Wortman; J Huang; M H S Goldman; G H Goldman
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

Review 3.  Sterol 14 alpha-demethylase, an abundant and essential mixed-function oxidase.

Authors:  Michael R Waterman; Galina I Lepesheva
Journal:  Biochem Biophys Res Commun       Date:  2005-08-24       Impact factor: 3.575

Review 4.  The evolutionary significance of cis-regulatory mutations.

Authors:  Gregory A Wray
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

5.  Structural and functional characterization of the coxsackievirus B3 CRE(2C): role of CRE(2C) in negative- and positive-strand RNA synthesis.

Authors:  Mark J M van Ooij; Dorothee A Vogt; Aniko Paul; Christian Castro; Judith Kuijpers; Frank J M van Kuppeveld; Craig E Cameron; Eckard Wimmer; Raul Andino; Willem J G Melchers
Journal:  J Gen Virol       Date:  2006-01       Impact factor: 3.891

6.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

Review 7.  P450 inhibitors of use in medical treatment: focus on mechanisms of action.

Authors:  H Vanden Bossche; L Koymans; H Moereels
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

8.  Multi-azole resistance in Aspergillus fumigatus.

Authors:  Susan J Howard; Ian Webster; Caroline B Moore; Rebecca E Gardiner; Steven Park; David S Perlin; David W Denning
Journal:  Int J Antimicrob Agents       Date:  2006-10-10       Impact factor: 5.283

9.  Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate.

Authors:  John W Slaven; Michael J Anderson; Dominique Sanglard; Graham K Dixon; Jacques Bille; Ian S Roberts; David W Denning
Journal:  Fungal Genet Biol       Date:  2002-08       Impact factor: 3.495

10.  Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.

Authors:  Li Xiao; Vincent Madison; Andrew S Chau; David Loebenberg; Robert E Palermo; Paul M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more
  73 in total

1.  Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.

Authors:  Yong Chen; Zhongyi Lu; Jingjun Zhao; Ziying Zou; Yanwen Gong; Fen Qu; Zhiyao Bao; Guangbin Qiu; Mingsheng Song; Qing Zhang; Lin Liu; Mandong Hu; Xuelin Han; Shuguang Tian; Jingya Zhao; Fangyan Chen; Changjian Zhang; Yansong Sun; Paul E Verweij; Liuyu Huang; Li Han
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 2.  Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.

Authors:  Jacques F Meis; Anuradha Chowdhary; Johanna L Rhodes; Matthew C Fisher; Paul E Verweij
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-05       Impact factor: 6.237

Review 3.  Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.

Authors:  Simone M T Camps; Jan W M van der Linden; Yi Li; Ed J Kuijper; Jaap T van Dissel; Paul E Verweij; Willem J G Melchers
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.

Authors:  Pilar Escribano; Sandra Recio; Teresa Peláez; Milagros González-Rivera; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

5.  Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India.

Authors:  Cheshta Sharma; Rakesh Kumar; Nitin Kumar; Aradhana Masih; Dinesh Gupta; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 6.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

7.  First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France.

Authors:  Rose-Anne Lavergne; Florent Morio; Loïc Favennec; Stéphane Dominique; Jacques F Meis; Gilles Gargala; Paul E Verweij; Patrice Le Pape
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

8.  First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.

Authors:  K M T Astvad; R H Jensen; T M Hassan; E G Mathiasen; G M Thomsen; U G Pedersen; M Christensen; O Hilberg; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

Review 9.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

10.  An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus.

Authors:  Cau D Pham; Shawn R Lockhart
Journal:  Curr Fungal Infect Rep       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.